COMPANY PROFILE · UPDATED 18 NOV 2025

Metsera

Metsera operates as a clinical-stage biopharmaceutical company.

metsera.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2022
Headcount: 22
Open roles: 0
Last raised: IPO · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Metsera

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$505,000,000

Investors

GvAlpha Wave GlobalArch Venture PartnersDeep Track CapitalF-Prime CapitalFidelity InvestmentsJanus Henderson InvestorsMubadala Capital VenturesNewpath ManagementRA Capital ManagementSVFSymBiosisT. Rowe PriceVenrock Healthcare Capital PartnersViking Global InvestorsWellington Management

Funding rounds

IPO
UndisclosedJan 1, 2025
Series B
Venrock Healthcare Capital Partners, Wellington Management, Janus Henderson Investors, Fidelity Investments, Arch Venture Partners, RA Capital Management, GV, Newpath Management, Viking Global Investors, Deep Track Capital, SymBiosis, SVF, Alpha Wave Global, T. Rowe Price
$215MNov 12, 2024
Series A
Arch Venture Partners, SVF, Newpath Management, Mubadala Capital Ventures, GV, F-Prime Capital
$290MApr 17, 2024

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Industries

Medical Organizations Health Care Companies Biotechnology Companies

LOCATIONS

Where they work

Metsera Headquarters Location

3 World Trade Center, New York, NY, 10007

Loading map…